title: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
abstract: This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.
authors.affiliation: 1 University of Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany.
authors.forename: Claus F
authors.identifier: 0000-0002-9798-2527
authors.initials: CF
authors.lastname: Vogelmeier
authors.affiliation: 2 Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
authors.forename: Gerard J
authors.initials: GJ
authors.lastname: Criner
authors.affiliation: 3 New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York.
authors.forename: Fernando J
authors.initials: FJ
authors.lastname: Martinez
authors.affiliation: 4 University of Texas Health Science Center, San Antonio, Texas.|5 South Texas Veterans Health Care System, San Antonio, Texas.
authors.forename: Antonio
authors.initials: A
authors.lastname: Anzueto
authors.affiliation: 6 National Heart and Lung Institute, Imperial College, London, United Kingdom.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Barnes
authors.affiliation: 7 McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
authors.forename: Jean
authors.initials: J
authors.lastname: Bourbeau
authors.affiliation: 8 Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: Bartolome R
authors.initials: BR
authors.lastname: Celli
authors.affiliation: 9 State Key Lab for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
authors.forename: Rongchang
authors.initials: R
authors.lastname: Chen
authors.affiliation: 10 University of Leuven, Leuven, Belgium.
authors.forename: Marc
authors.initials: M
authors.lastname: Decramer
authors.affiliation: 11 University of Modena and Reggio Emilia, Modena, Italy.
authors.forename: Leonardo M
authors.initials: LM
authors.lastname: Fabbri
authors.affiliation: 12 Faculty of Medicine, Flinders University, Bedford Park, South Australia, Australia.
authors.forename: Peter
authors.initials: P
authors.lastname: Frith
authors.affiliation: 13 Royal Devon and Exeter Hospital, Exeter, United Kingdom.
authors.forename: David M G
authors.initials: DM
authors.lastname: Halpin
authors.affiliation: 14 Universidad de la República, Hospital Maciel, Montevideo, Uruguay.
authors.forename: M Victorina
authors.initials: MV
authors.lastname: López Varela
authors.affiliation: 15 Hokkaido University School of Medicine, Sapporo, Japan.
authors.forename: Masaharu
authors.initials: M
authors.lastname: Nishimura
authors.affiliation: 16 Hôpital Cochin (Assistance Publique-Hôpitaux de Paris), University Paris Descartes, Paris, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Roche
authors.affiliation: 17 Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain.
authors.forename: Roberto
authors.initials: R
authors.lastname: Rodriguez-Roisin
authors.affiliation: 18 St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: Don D
authors.initials: DD
authors.lastname: Sin
authors.affiliation: 19 University of Manchester, Manchester, United Kingdom.
authors.forename: Dave
authors.initials: D
authors.lastname: Singh
authors.affiliation: 20 University Hospital, Birmingham, United Kingdom; and.
authors.forename: Robert
authors.initials: R
authors.lastname: Stockley
authors.affiliation: 19 University of Manchester, Manchester, United Kingdom.
authors.forename: Jørgen
authors.initials: J
authors.lastname: Vestbo
authors.affiliation: 6 National Heart and Lung Institute, Imperial College, London, United Kingdom.
authors.forename: Jadwiga A
authors.initials: JA
authors.lastname: Wedzicha
authors.affiliation: 21 Hospital Clínic, Universitat de Barcelona, Centro de Investigación Biomédica en Red de Enfermedade Respiratorias, Barcelona, Spain.
authors.forename: Alvar
authors.initials: A
authors.lastname: Agustí
mesh_terms: D001993:Bronchodilator Agents / Q000627:therapeutic use; D014943:Global Health; D006801:Humans; D038622:Internationality; D029424:Pulmonary Disease, Chronic Obstructive / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy*; D012307:Risk Factors; D013147:Spirometry
chemical_list: D001993:Bronchodilator Agents
keywords: COPD diagnosis; COPD management; COPD prevention; chronic obstructive pulmonary disease